KindlyMD (NASDAQ:NAKA) Posts Earnings Results, Misses Estimates By $0.05 EPS

KindlyMD (NASDAQ:NAKA) posted its quarterly earnings results on Wednesday. The company reported ($0.06) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.05), Zacks reports. KindlyMD had a negative net margin of 244.00% and a negative return on equity of 131.09%.

KindlyMD Stock Down 4.2%

NASDAQ:NAKA traded down $0.02 during mid-day trading on Wednesday, reaching $0.54. 8,569,646 shares of the company’s stock were exchanged, compared to its average volume of 9,180,055. KindlyMD has a one year low of $0.52 and a one year high of $34.77. The business’s fifty day moving average is $1.12. The stock has a market capitalization of $236.11 million, a price-to-earnings ratio of -0.62 and a beta of 30.71.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the stock. Zacks Research raised shares of KindlyMD to a “hold” rating in a research report on Friday, October 17th. B. Riley assumed coverage on shares of KindlyMD in a research note on Wednesday, October 15th. They set a “buy” rating and a $2.00 target price for the company. Maxim Group assumed coverage on shares of KindlyMD in a research note on Wednesday, September 3rd. They issued a “buy” rating and a $8.00 price target on the stock. Weiss Ratings reissued a “sell (d-)” rating on shares of KindlyMD in a report on Wednesday, October 8th. Finally, Wall Street Zen upgraded shares of KindlyMD to a “sell” rating in a research report on Saturday, October 18th. Two analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Hold” and an average price target of $5.00.

About KindlyMD

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population.